B. Riley Wealth Advisors, Inc. - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$24,000
+4.3%
16,0000.0%0.01%0.0%
Q4 2016$23,000
-37.8%
16,000
-23.8%
0.01%
-28.6%
Q3 2016$37,000
+32.1%
21,000
+31.2%
0.01%
+16.7%
Q2 2016$28,000
-12.5%
16,0000.0%0.01%
-14.3%
Q1 2016$32,000
-3.0%
16,000
-5.9%
0.01%0.0%
Q4 2015$33,0000.0%17,000
-1.2%
0.01%
-12.5%
Q3 2015$33,000
-62.5%
17,200
-9.0%
0.01%
-63.6%
Q2 2015$88,000
+528.6%
18,900
+361.0%
0.02%
Q4 2014$14,0000.0%4,100
-72.7%
0.00%
-100.0%
Q1 2014$14,00015,0000.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 7,500,000$34,800,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,983,710$32,404,0001.08%
DAFNA Capital Management LLC 189,000$877,0000.74%
Lyons Wealth Management, LLC. 56,665$264,0000.30%
Telemetry Investments, L.L.C. 110,000$510,0000.23%
Callan Capital, LLC 232,000$1,076,0000.23%
OXFORD ASSET MANAGEMENT LLP 968,446$4,494,0000.12%
FEDERATED HERMES, INC. 5,641,200$26,175,0000.08%
HRT FINANCIAL LP 31,973$148,0000.07%
WELLINGTON MANAGEMENT GROUP LLP 33,885,551$157,230,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders